| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/17/2006 | US7122193 Comprising peptide analogues which have a half-life which is clearly superior to that of natural proteins or that of synthetic peptides which are or are not derived from these natural proteins |
| 10/17/2006 | US7122192 Porcine circoviruses, vaccines and diagnostic reagents |
| 10/17/2006 | US7122191 Microfluidized oil-in-water emulsions and vaccine compositions |
| 10/17/2006 | US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 10/17/2006 | US7122189 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 10/17/2006 | US7122188 For use in diagnostic method for the detection of infection in humans more particularly the absence or presence of antibodies to proteins of the lymphadenopathy retrovirus (LAV), especially the p18 and/or the p25 proteins |
| 10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
| 10/17/2006 | US7122186 For use in diagnostic, therapeutic, and industrial contexts |
| 10/17/2006 | US7122185 Nucleic acids; prevent humans lymphocyte virus infection; genetic engineering; transformation cells |
| 10/17/2006 | US7122184 Monoclonal antibody for use in prevention of fungal infections |
| 10/17/2006 | US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 10/17/2006 | US7122180 DNA vectors containing mutated HIV proviruses |
| 10/17/2006 | US7122179 Live genetically attenuated malaria vaccine |
| 10/17/2006 | CA2359659C Method for quality control of an attenuated varicella live vaccine |
| 10/17/2006 | CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/17/2006 | CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 10/12/2006 | WO2006108167A1 Bioactive stents for type ii diabetics and methods for use thereof |
| 10/12/2006 | WO2006108130A2 Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample |
| 10/12/2006 | WO2006108070A2 Inhibition of p-glycoprotein using act modulators and uic2 monoclonal antibody |
| 10/12/2006 | WO2006107945A2 Use of rip in treating staphylococcus aureus infections |
| 10/12/2006 | WO2006107944A2 Improved method and apparatus for treating bacterial infections in devices |
| 10/12/2006 | WO2006107786A2 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 10/12/2006 | WO2006107708A1 Treatment of disease caused by excess free hemoglobin |
| 10/12/2006 | WO2006107617A2 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 10/12/2006 | WO2006107298A1 Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules |
| 10/12/2006 | WO2006107097A1 Nasal vaccine |
| 10/12/2006 | WO2006106959A1 Anti-cd-20 monoclonal antibody |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106905A1 Process for production of polypeptide by regulation of assembly |
| 10/12/2006 | WO2006106903A1 sc(Fv)2 STRUCTURAL ISOMERS |
| 10/12/2006 | WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding |
| 10/12/2006 | WO2006106245A1 Combination consisting of a histological or cytological fixing solution and of one or more photoactivatable compounds of the family of quinones, in particular, hypericin, hypocrellin a and hyprcrellin b |
| 10/12/2006 | WO2006106166A1 Attenuated live strain of staphylococcus aureus as a vaccine against bovine mastitis |
| 10/12/2006 | WO2006105972A1 Transgenic organism expressing cd40l and uses thereof |
| 10/12/2006 | WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis |
| 10/12/2006 | WO2006105597A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 10/12/2006 | WO2006088664A3 Flavivirus ns5a proteins for the treatment of hiv |
| 10/12/2006 | WO2006087637A3 Anti her2/neu antibody |
| 10/12/2006 | WO2006086586A3 Anti-interferon alpha monoclonal antibodies and methods for use |
| 10/12/2006 | WO2006081587A3 Stabilized liquid polypeptide formulations |
| 10/12/2006 | WO2006081320A3 Pharmaceutical formulation |
| 10/12/2006 | WO2006079989A3 Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
| 10/12/2006 | WO2006073443A3 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 10/12/2006 | WO2006065137A3 Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria |
| 10/12/2006 | WO2006062807A3 Compositions with enhanced immunogenicity |
| 10/12/2006 | WO2006052826A3 Methods for preparing cells and viruses |
| 10/12/2006 | WO2006052820A3 Human immunodeficiency virus vaccine |
| 10/12/2006 | WO2006034354A3 Methods of diagnosing and treating vhl associated tumors and sporadic renal cell carcinoma, other vhl sporadic counterpart tumors and non-tumor lesions which co-express epo and the epo receptor |
| 10/12/2006 | WO2006033742A3 Engineered antibody fragment that irreversibly binds an antigen |
| 10/12/2006 | WO2006020706A3 Tie complex binding proteins |
| 10/12/2006 | WO2006020258A3 Novel tetravalent bispecific antibody |
| 10/12/2006 | WO2005123774A3 Antibodies to west nile virus polypeptides |
| 10/12/2006 | WO2005105978A3 Drying process for preserving an active agent as a highly viscous liquid |
| 10/12/2006 | WO2005089262A3 Novel peanut skin extract as a vaccine adjuvant |
| 10/12/2006 | WO2005065384A3 Electronic trading data integration and protection system |
| 10/12/2006 | WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 10/12/2006 | US20060230465 K203 gene and protein |
| 10/12/2006 | US20060229438 Monoclonal antibody derived peptide inhibitors for mycobacterial dna gyrase |
| 10/12/2006 | US20060229433 Modified antiviral peptides with increased activity and cell membrane affinity |
| 10/12/2006 | US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides |
| 10/12/2006 | US20060228780 Chromatographic method and system for purifying a botulinum toxin |
| 10/12/2006 | US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 10/12/2006 | US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy |
| 10/12/2006 | US20060228710 Novel therapeutic targets in cancer |
| 10/12/2006 | US20060228422 Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration |
| 10/12/2006 | US20060228382 Lipoglycan compositions and methods of treating parasitic infections |
| 10/12/2006 | US20060228381 Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation |
| 10/12/2006 | US20060228380 formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children; provides coverage for serotypes 6A and 19A |
| 10/12/2006 | US20060228379 Novel microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities |
| 10/12/2006 | US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 10/12/2006 | US20060228377 Gram-positive bacteria deprived of HtrA protease activity and their uses |
| 10/12/2006 | US20060228376 Virosome-like-particles |
| 10/12/2006 | US20060228375 Induction of mucosal immunity by vaccination via the skin route |
| 10/12/2006 | US20060228374 Oral DNA composition for hepatitis B virus chronic infection |
| 10/12/2006 | US20060228373 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 10/12/2006 | US20060228372 Methods for modulating angiogenesis |
| 10/12/2006 | US20060228371 Immunological control of beta-amyloid levels in vivo |
| 10/12/2006 | US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors |
| 10/12/2006 | US20060228369 Stabilization and preservation of temperature-sensitive vaccines |
| 10/12/2006 | US20060228368 Method of protecting against staphylococcal infection |
| 10/12/2006 | US20060228367 Antibodies against mammalian metapneumovirus |
| 10/12/2006 | US20060228366 Tumor specific monoclonal antibodies |
| 10/12/2006 | US20060228365 Protein and gene involved in myocyte differentiation |
| 10/12/2006 | US20060228364 Serum albumin binding peptides for tumor targeting |
| 10/12/2006 | US20060228363 Monoclonal antibody therapy for pancreas cancer |
| 10/12/2006 | US20060228362 Novel protease gene |
| 10/12/2006 | US20060228361 Dicer interacting proteins and uses therefor |
| 10/12/2006 | US20060228360 Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12 |
| 10/12/2006 | US20060228359 antibody; host cell; hybridoma; |
| 10/12/2006 | US20060228358 Antibody molecules having specificity for human il-1 beta |
| 10/12/2006 | US20060228357 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 10/12/2006 | US20060228356 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease |
| 10/12/2006 | US20060228355 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
| 10/12/2006 | US20060228354 Modified ADAMTS4 molecules and method of use thereof |
| 10/12/2006 | US20060228353 PTH1R and PTH3R receptors, methods and uses thereof |
| 10/12/2006 | US20060228352 TRAIL and methods of modulating T cell activity and adaptive immune responses using TRAIL |
| 10/12/2006 | US20060228351 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 10/12/2006 | US20060228350 Framework-shuffling of antibodies |
| 10/12/2006 | US20060228349 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases |